ALLE
30
5
LUV
57
5
CHD
62
8
LYB
32
3
AIZ
66
9
LOW
46
6
MAC
65
3
HPQ
66
-4
HOG
29
-7
NWL
24
2
OXY
44
4
BAC
50
6
LRCX
55
-3
CSX
41
4
VRSN
54
6
VTR
69
5
KEY
37
6
TAP
40
3
CI
58
13
TDC
52
5
ALLE
30
5
LUV
57
5
CHD
62
8
LYB
32
3
AIZ
66
9
LOW
46
6
MAC
65
3
HPQ
66
-4
HOG
29
-7
NWL
24
2
OXY
44
4
BAC
50
6
LRCX
55
-3
CSX
41
4
VRSN
54
6
VTR
69
5
KEY
37
6
TAP
40
3
CI
58
13
TDC
52
5
Financhill
Back

Eliem Therapeutics Stock Predictions

Buy
62

ELYM
Eliem Therapeutics

Last Price:
7.68
Seasonality Move:
-11.81%

7 Day Trial

ALL ACCESS PASS

$ 7

Eliem Therapeutics Stock Forecast

  • Over the next 52 weeks, Eliem Therapeutics has on average historically risen by 67.2% based on the past 2 years of stock performance.
  • Eliem Therapeutics has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
  • Is Eliem Therapeutics Stock Undervalued?
    The current Eliem Therapeutics [ELYM] share price is $7.59. The Score for ELYM is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • ELYM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Eliem Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Eliem Therapeutics has on average historically risen by 67.2% based on the past 2 years of stock performance.

Eliem Therapeutics Stock Rating

Buy
62
Eliem Therapeutics (ELYM) is a Buy

Is Eliem Therapeutics overpriced?

  • Eliem Therapeutics has risen higher in 1 of those 2 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%

Eliem Therapeutics Stock Price History

Is ELYM stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ELYM is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
eliemtx.com

52-Week Data

52-Week High:
11.55
52-Week Low:
2.34

Prediction Charts

Market Cap:
220.8M
Price in USD:
7.59
Volume:
65.52K
Beta:
-0.33

Technical Analysis

SMA50:
5.64
SMA100:
4.19
SMA200:
3.41
52-Wk Change:
159.93%

Stock Predictions

  • Is Eliem Therapeutics stock public?
    Yes, Eliem Therapeutics is a publicly traded company.
  • What is the Eliem Therapeutics stock quote today?
    The Eliem Therapeutics stock price is 7.59 USD today.
  • How to buy Eliem Therapeutics stock online?
    You can buy Eliem Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-13 8.22 8.41 9.19 8.22
May-14 8.45 8.19 8.81 8.02
May-15 8.49 7.99 8.50 7.86
May-16 7.87 8.18 8.99 7.67
May-17 8.06 8.25 8.61 7.76
May-20 8.48 8.20 8.91 8.14
May-21 8.09 7.84 8.18 7.67
May-22 7.88 7.87 8.18 7.60
May-23 7.76 7.44 8.30 7.30
May-24 7.42 7.41 7.74 7.03
May-28 7.52 7.66 7.70 7.19
May-29 7.70 7.63 8.07 7.44
May-30 7.73 7.66 8.05 7.54
May-31 7.75 7.59 8.30 7.56

Eliem Therapeutics Earnings

Eliem Therapeutics Earnings Report: Per Share Eliem Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Eliem Therapeutics Forecast Revenue Growth

Eliem Therapeutics Stock Analysis: Historical quarterly revenues per share for Eliem Therapeutics and historical quarterly revenue growth:

* Eliem Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.